| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/04/2006 | CN1717228A Pharmaceutical composition comprising a LTB4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 01/04/2006 | CN1715926A Neuregulin mutant, screening method and use |
| 01/04/2006 | CN1715392A Ginseng and Chinese wolfberry fruit health wine |
| 01/04/2006 | CN1715291A Synthesis of oleanolic acid succinic acid monoester and its medicinal preparation for treating chronic and acute hepatitis |
| 01/04/2006 | CN1715280A Aryl fused azapolycyclic compounds |
| 01/04/2006 | CN1714864A Nano grade polypeptide anti-dental caries material and producing method and tooth-paste containing said material |
| 01/04/2006 | CN1714861A Thymus penta peptide slow releasing micro ball and its preparing method |
| 01/04/2006 | CN1714860A Chinese medicine composition for dissolving stone, anti-inflammation, analgesia and bacteriostat and its preparing method |
| 01/04/2006 | CN1714843A Health medicinal wine for nourishing kidney |
| 01/04/2006 | CN1714842A Chinese medicine composition for smoothing liver-gallbladder and clearing heat and detoxicating and its preparing method |
| 01/04/2006 | CN1714834A Medicine for treating hepatitis B hepatitis C, hepatitis cirrhosis |
| 01/04/2006 | CN1714817A Stomatitis film agent and its preparing method |
| 01/04/2006 | CN1714815A Bee glue and saussurea involucrata wine |
| 01/04/2006 | CN1714811A Radix bupleuri dripping pill and its preparing method |
| 01/04/2006 | CN1714810A Drugs, foods, drinks and feeds containing cocoa component |
| 01/04/2006 | CN1714809A Drugs, foods, drinks and feeds containing cocoa component |
| 01/04/2006 | CN1714802A Nourishing and health type high quality natural food antler glue capsule |
| 01/04/2006 | CN1714801A New dosage form antler glue capsule of nourishing and health type traditional Chinese patiented medicine |
| 01/04/2006 | CN1714793A Famciclovir slow-releasing capsule for anti-virus treatment and its producing method |
| 01/04/2006 | CN1714790A Fibrauretine transfusion preparation and its preparing method |
| 01/04/2006 | CN1714786A Medicinal composition of silibin |
| 01/04/2006 | CN1714784A Industrial producing process for breath refreshing tablet |
| 01/04/2006 | CN1714783A Implantable particles for tissue bulking and the treatment |
| 01/04/2006 | CN1234839C Donkey-hide gelatin-ginseng-radix astragali wine |
| 01/04/2006 | CN1234838C Nutritive indianmulberry liquor |
| 01/04/2006 | CN1234727C Human thymosin alpha protogene mutant synthesis, expression and use |
| 01/04/2006 | CN1234698C Nitric oxide donors based on metallic centers |
| 01/04/2006 | CN1234688C 3-arylindole and their use as cb2 receptor agonists |
| 01/04/2006 | CN1234417C Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same |
| 01/04/2006 | CN1234405C Medicine for eliminating hepatitis virus |
| 01/04/2006 | CN1234403C Medicine for treating gastric disease |
| 01/04/2006 | CN1234400C Medicine for treating viral hepatitis B |
| 01/04/2006 | CN1234389C Chinese traditional medicine for treating oral disease and its preparing process |
| 01/04/2006 | CN1234384C Chinese medicinal preparation for preventing and curing enteric disease of animal and poultry and its preparation method |
| 01/04/2006 | CN1234381C Medicine compositions for treating hepatitis, and its preparing method |
| 01/04/2006 | CN1234349C Fragrance chewing gum for preventing tooth-decay |
| 01/04/2006 | CN1234342C Chinese medicinal tooth-paste |
| 01/03/2006 | US6982319 Protein for use in the treatment of liver disorders, fibrosis, cancer, rheumatoid arthritis and glomeronephritis |
| 01/03/2006 | US6982286 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO), treat an inflammatory disease or condition, a disease related to carbohydrate metabolism, smooth muscle cell function |
| 01/03/2006 | US6982283 Method for treating drug-induced constipation |
| 01/03/2006 | US6982278 For modulating a peroxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus |
| 01/03/2006 | US6982275 Oxidizing a benzylthio- or pyridylmethylthio-substituted indole or benzimidazole derivative |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982270 1-Phenyl-2-oxo-3,4-dihydro-6-phenylaminoquinazoline for example; cytokine suppressive anti-inflammatory drugs; combination therapy |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982259 N-heterocyclic derivatives as NOS inhibitors |
| 01/03/2006 | US6982253 Liquid formulation of decitabine and use of the same |
| 01/03/2006 | CA2343236C 4,4-biarylpiperidine derivatives |
| 01/03/2006 | CA2339992C Orally disintegrable tablet forming a viscous slurry |
| 01/03/2006 | CA2176117C Generation of high titers of recombinant aav vectors |
| 12/29/2005 | WO2005123718A2 Benzimidazolone carboxylic acid derivatives |
| 12/29/2005 | WO2005123711A1 Bicyclol glycosides and the preparation method and uses thereof |
| 12/29/2005 | WO2005123100A1 Lactic bacteria and their use in the prevention of diarrhea |
| 12/29/2005 | WO2005123098A2 Preventing gastrointestinal side-effects with strontium salts |
| 12/29/2005 | WO2005123058A1 Antiaging agent |
| 12/29/2005 | WO2005096717A3 Agent exhibiting hepatoprotective properties |
| 12/29/2005 | WO2003012122A3 Crystallized structure of type iv collagen nc1 domain hexamer |
| 12/29/2005 | US20050289660 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 12/29/2005 | US20050288501 Reducing a 2-(protected amino)-3-(piperazin-1-yl, N-morpholinyl, or N-thiomorpholinyl) propanoate, deprotecting the amine, and reacting with t-butylisothiocyanate |
| 12/29/2005 | US20050288487 Human mast cell-expressed membrane proteins |
| 12/29/2005 | US20050288368 Compositions and methods for treating and preventing necrosis |
| 12/29/2005 | US20050288366 Administering N-(4-carboxybutyl)-N-(p-carboxybenzyl)-benzyl- or phenethyl-amine derivatives: 4-({(4-Carboxybutyl)[3-(4-cyclohexylphenoxy)benzyl]amino}methyl)-benzoic acid; stimulate soluble guanylate cyclase also via a novel mechanism of action which takes place without involvement of the heme group |
| 12/29/2005 | US20050288363 Therapeutic compositions and methods of use |
| 12/29/2005 | US20050288357 e.g. 4-(2-{2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)benzoic acid; antiinflammatory, hypotensive, antiulcer agent |
| 12/29/2005 | US20050288356 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 12/29/2005 | US20050288355 Combination therapy wherein a serotonin reuptake inhibitor is used |
| 12/29/2005 | US20050288353 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 12/29/2005 | US20050288337 Novel compounds |
| 12/29/2005 | US20050288323 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizine |
| 12/29/2005 | US20050288313 Synergistically combined with immunomodulators or antiinflammtory agents; treating rheumatoid arthritis; inhibiting organ transplant rejection; Janus Kinase 3 inhibitors such as CP 690550, 3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile |
| 12/29/2005 | US20050288312 Bicyclic pyridine and pyrimidine p38 kinase inhibitors |
| 12/29/2005 | US20050288305 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 12/29/2005 | US20050288303 Cyclic protein tyrosine kinase inhibitors |
| 12/29/2005 | US20050288285 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 12/29/2005 | US20050288254 Treating sepsis or septic shock by administering 1-stearoyl, 1-palmitoyl-, 1-myristoyl- lysophosphatidylcholine, or 1-oleoyllysophosphatidylcholine or sphingosylphosphorylcholine. |
| 12/29/2005 | US20050288219 Osteoprotegerin in milk |
| 12/29/2005 | US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 12/29/2005 | US20050287546 Novel proteases |
| 12/29/2005 | US20050287235 2 to 5% Ulteria salicifolia extract; 1 to 3% Asparagus racemosus extract; 2 to 4% Foeniculum vulgare extract; 3 to 5% Ficus glomerata extract; administered at a dose of 100 to 200 mg/kg; treating stomach discomfort, stomach ache, intestinal discomfort, gastric ulcer, duodenal ulcer or diarrhea |
| 12/29/2005 | US20050287168 Recombinant spores |
| 12/29/2005 | US20050287144 For the modulation of signal activities controlled by NF-kappa B-inducing kinase (NIK); cancer , rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, asthma, cardiac infarct, Alzheimer's disease, or atherosclerosis |
| 12/29/2005 | DE102004028144A1 Using extracts (containing marine thistle weeds, pancreatin and cape aloe) for the treatment of digestive complaints and/or diseases of the digestive tract and halitosis |
| 12/29/2005 | DE102004027924A1 Arzneiform, enthaltend den Wirkstoff Cholylsarcosin Dosage form comprising the active ingredient cholylsarcosine |
| 12/29/2005 | CA2570119A1 A pharmaceutical composition having prokinetic effect |
| 12/29/2005 | CA2569913A1 Amino-halogen-imidazopyridines as proton pump inhibitors |
| 12/29/2005 | CA2569697A1 A pharmaceutical composition and its use |
| 12/29/2005 | CA2568643A1 Treatment of non alcoholic steatotic hepatitis (nash) |
| 12/28/2005 | EP1609852A1 Bifidobacteria and preparations containing them |
| 12/28/2005 | EP1609803A1 Modified antibody against cd22 and utilization thereof |
| 12/28/2005 | EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 12/28/2005 | EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine |
| 12/28/2005 | EP1609476A1 Composition for treating hepatitis c |
| 12/28/2005 | EP1609472A1 Therapeutic agent for hemorrhoidal disease |
| 12/28/2005 | EP1609468A2 A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis |
| 12/28/2005 | EP1608680A2 Glp-2 derivatives |
| 12/28/2005 | EP1608366A1 Use of ritonavir for the treatment of unconjugated hyperbilirubinemia |
| 12/28/2005 | EP1608363A1 Methods for treating inflammatory conditions or inhibiting jnk |
| 12/28/2005 | EP1608312A2 Methods for obtaining colonization factors from bacterial strains |
| 12/28/2005 | EP1497288B1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament |
| 12/28/2005 | EP1377593B1 2-amino-propanol derivatives |